What are we campaigning for?
Target Ovarian Cancer research found that nearly half of women are waiting three months or more from first approaching their GP to receiving a diagnosis.
It is vital that more women know the symptoms of ovarian cancer so they visit their GP at the earliest opportunity but also that GPs can refer women for diagnostic tests promptly and the route towards receiving a diagnosis is as short as possible.
What needs to change?
- Guidelines for diagnosing ovarian cancer: England, Wales and Northern Ireland follow guidelines that recommend women with possible symptoms of ovarian cancer are referred for a CA125 blood test. If this measures higher than normal levels of CA125 protein, GPs should then refer women for an ultrasound. In Scotland however, where different guidelines are followed, women can be referred for a CA125 blood test and an ultrasound at the same time. Target Ovarian Cancer is calling for this to be the case across the UK to speed up the time taken to diagnose ovarian cancer.
- Rapid Diagnostic Centres: The NHS Long Term Plan commits to more Rapid Diagnostic Centres being rolled out. These centres are designed to help GPs when it isn’t clear or they are not sure where to refer a patient. Target Ovarian Cancer is calling for Rapid Diagnostic Centres to be rolled out across the country and accessible to all patients with vague or less specific symptoms.
- New targets: The Faster Diagnosis Standard was set out in the The NHS Long Term Plan. The target says that all patients suspected of having cancer should have cancer diagnosed or ruled out in 28 days. Target Ovarian Cancer will continue campaigning to ensure the target is met so women who may have ovarian cancer receive a diagnosis as soon as possible.
Read related news
News
Thursday 4 June 2020
Government advice has changed since this article was published in early June 2020. For the most up-to-date shielding advice please see the relevant recommendations for England, Scotland, Wales and Northern Ireland.
A message from our Head of Services, Lizzy Rodgers, about coronavirus/Covid-19 and...
News
Wednesday 3 June 2020
This week our immunotherapy project led by Dr Martin Miller at the University of Cambridge revealed an important new piece of the puzzle of developing more effective treatments for the most common form of ovarian cancer. The paper, published in high-profile journal Nature Genetics, has uncovered...
Blog
Thursday 28 May 2020
A message from our Chief Executive, Annwen Jones OBE, on the impact of the coronavirus pandemic and our commitment to supporting women with ovarian cancer, now and in the future.
The past few weeks have brought disruption like we’ve never seen before in the NHS. We’ve heard directly from people...
News
Tuesday 31 March 2020
Just weeks ago we could never have imagined we’d be facing a challenge like coronavirus together. This far into the crisis, we’re concentrating on one thing: being here for you. We are doing everything we possibly can to keep our services going, and now we need to ask for your help.
Donate to our...